Delivery Order SPE2DB20D3103-SPE2DB21FP1M0

Award Date 6/11/21
Potential Completion Date 6/14/21
Potential Value $2.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chesterbrook, PA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for pharmaceutical and medical supply delivery services provided by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, awarded by the Defense Logistics Agency (DLA), is a $1,357.08 delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,799.12 delivery order was issued by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies, including...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,698.36 for pharmaceutical products and medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $2,467.15 for pharmaceutical and medical supply distribution. The award was made by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. The contract covers a comprehensive range of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $4,018.95 awarded by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The IDC, which runs through November 2026, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare...
This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to the Defense Logistics Agency (DLA). The contract, valued at $1,306.11, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 and running through November 2026. This IDC enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical products...
This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $4,568.30, was awarded by the Defense Logistics Agency (DLA) and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The IDC, which runs through November 2026, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range...
This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for pharmaceutical and medical supply distribution services. The $3,885.62 Delivery Order was issued by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies, including...
This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, awarded by the Defense Logistics Agency (DLA), is a delivery order under a $999,999,999 Indefinite Delivery Contract (IDC) that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,886.84 for pharmaceutical and medical supplies. The contract is awarded by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies, including...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB21FP1M0
    Delivery Order

This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, awarded by the Defense Logistics Agency (DLA), is a $2,887.65 delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The IDC, which runs through November 2026, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. The contract covers a wide variety of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The award does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:32 AM